Nymox Pharmaceutical Corp (NYMX) Dividend History
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Last update 08/13/2022
Dividend Yield Summary
|Date||Amount Per Share||Note|